Erlacher M - Search Results

1

Venetoclax-based therapies in pediatric advanced MDS and relapsed/refractory AML: a multicenter retrospective analysis.

Masetti R, Baccelli F, Leardini D, Gottardi F, Vendemini F, Di Gangi A, Becilli M, Lodi M, Tumino M, Vinci L, Erlacher M, Strahm B, Niemeyer CM, Locatelli F. Masetti R, et al. Among authors: erlacher m. Blood Adv. 2023 Aug 22;7(16):4366-4370. doi: 10.1182/bloodadvances.2023010113. Blood Adv. 2023. PMID: 37216275 Free PMC article. No abstract available.

2

BH3-only proteins in cell death initiation, malignant disease and anticancer therapy.

Labi V, Erlacher M, Kiessling S, Villunger A. Labi V, et al. Among authors: erlacher m. Cell Death Differ. 2006 Aug;13(8):1325-38. doi: 10.1038/sj.cdd.4401940. Epub 2006 Apr 28. Cell Death Differ. 2006. PMID: 16645634 Review.

3

The Bcl-2 protein family and its role in the development of neoplastic disease.

Heiser D, Labi V, Erlacher M, Villunger A. Heiser D, et al. Among authors: erlacher m. Exp Gerontol. 2004 Aug;39(8):1125-35. doi: 10.1016/j.exger.2004.04.011. Exp Gerontol. 2004. PMID: 15288687 Review.

4

TCR signaling inhibits glucocorticoid-induced apoptosis in murine thymocytes depending on the stage of development.

Erlacher M, Knoflach M, Stec IE, Böck G, Wick G, Wiegers GJ. Erlacher M, et al. Eur J Immunol. 2005 Nov;35(11):3287-96. doi: 10.1002/eji.200526279. Eur J Immunol. 2005. PMID: 16224812 Free article.

5

FOXO3a-dependent regulation of Puma in response to cytokine/growth factor withdrawal.

You H, Pellegrini M, Tsuchihara K, Yamamoto K, Hacker G, Erlacher M, Villunger A, Mak TW. You H, et al. Among authors: erlacher m. J Exp Med. 2006 Jul 10;203(7):1657-63. doi: 10.1084/jem.20060353. Epub 2006 Jun 26. J Exp Med. 2006. PMID: 16801400 Free PMC article.

6

Improved HSC reconstitution and protection from inflammatory stress and chemotherapy in mice lacking granzyme B.

Carnevalli LS, Scognamiglio R, Cabezas-Wallscheid N, Rahmig S, Laurenti E, Masuda K, Jöckel L, Kuck A, Sujer S, Polykratis A, Erlacher M, Pasparakis M, Essers MA, Trumpp A. Carnevalli LS, et al. Among authors: erlacher m. J Exp Med. 2014 May 5;211(5):769-79. doi: 10.1084/jem.20131072. Epub 2014 Apr 21. J Exp Med. 2014. PMID: 24752302 Free PMC article.

7

Puma cooperates with Bim, the rate-limiting BH3-only protein in cell death during lymphocyte development, in apoptosis induction.

Erlacher M, Labi V, Manzl C, Böck G, Tzankov A, Häcker G, Michalak E, Strasser A, Villunger A. Erlacher M, et al. J Exp Med. 2006 Dec 25;203(13):2939-51. doi: 10.1084/jem.20061552. Epub 2006 Dec 18. J Exp Med. 2006. PMID: 17178918 Free PMC article.

8

hTERT: another brick in the wall of cancer cells.

Lamy E, Goetz V, Erlacher M, Herz C, Mersch-Sundermann V. Lamy E, et al. Among authors: erlacher m. Mutat Res. 2013 Apr-Jun;752(2):119-128. doi: 10.1016/j.mrrev.2012.12.005. Epub 2012 Dec 31. Mutat Res. 2013. PMID: 23287739 Review.

9

Apoptosis of leukocytes triggered by acute DNA damage promotes lymphoma formation.

Labi V, Erlacher M, Krumschnabel G, Manzl C, Tzankov A, Pinon J, Egle A, Villunger A. Labi V, et al. Among authors: erlacher m. Genes Dev. 2010 Aug 1;24(15):1602-7. doi: 10.1101/gad.1940210. Genes Dev. 2010. PMID: 20679395 Free PMC article.

10

p14-MP1-MEK1 signaling regulates endosomal traffic and cellular proliferation during tissue homeostasis.

Teis D, Taub N, Kurzbauer R, Hilber D, de Araujo ME, Erlacher M, Offterdinger M, Villunger A, Geley S, Bohn G, Klein C, Hess MW, Huber LA. Teis D, et al. Among authors: erlacher m. J Cell Biol. 2006 Dec 18;175(6):861-8. doi: 10.1083/jcb.200607025. J Cell Biol. 2006. PMID: 17178906 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

114 results

Search Page